VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,894 | -9.5% | 1,074 | +1.2% | 0.00% | – |
| Q2 2023 | $31,939 | -36.7% | 1,061 | -32.0% | 0.00% | -100.0% |
| Q1 2023 | $50,490 | +36.0% | 1,561 | +20.5% | 0.00% | – |
| Q4 2022 | $37,115 | +19.7% | 1,295 | 0.0% | 0.00% | – |
| Q3 2022 | $31,000 | +40.9% | 1,295 | +62.9% | 0.00% | – |
| Q2 2022 | $22,000 | -51.1% | 795 | -32.7% | 0.00% | -100.0% |
| Q1 2022 | $45,000 | -38.4% | 1,181 | -48.3% | 0.00% | 0.0% |
| Q4 2021 | $73,000 | +9.0% | 2,284 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -13.0% | 2,267 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | +14.9% | 2,267 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $67,000 | -5.6% | 2,067 | +4.3% | 0.00% | -50.0% |
| Q4 2020 | $71,000 | – | 1,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |